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Mehee Choi1,4, Tamer Refaat1,5, Malisa S Lester2, Ian Bacchus1, Alfred W Rademaker3 and Bharat B Mittal1*Abstract
Objectives: Limiting radiation dose to the larynx can diminish effects of laryngeal dysfunction. However, no clear
guidelines exist for defining the larynx and its substructures consistently on cross-sectional imaging. This study
presents computed tomography (CT)- and magnetic resonance imaging (MRI)-based guidelines for contouring
laryngeal organs-at-risk (OARs).
Materials and Methods: Standardized guidelines for delineating laryngeal OARs were devised and used to delineate
on CT and MRI for head-and-neck cancer patients. Volumetric comparisons were performed to evaluate consistency
and reproducibility of guideline-based contours.
Results: For the initial 5 patients the mean CT and MRI based larynx volume did not differ significantly between
imaging modalities; 34.39 ± 9.85 vs. 35.01 ± 9.47 (p = .09). There was no statistical difference between the CT
based mean laryngeal volume in the subsequent 44 patients compared to the initial 5 patients outlined on CT
and the MRI scan (p = 0.53 and 0.62). The OAR volume for laryngeal substructures were not statistically different
among patients or between imaging modalities. Once established, the guidelines were easy to follow.
Conclusion: The guidelines developed provide a precise method for delineating laryngeal OARs. These guidelines
need to be validated and clinical significance of outlining laryngeal substructures and dose-volume constraints should
be investigated before routine implementation in clinic practice.
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Organs at riskBackground
The larynx plays an important role in speech and swal-
lowing. Progressive laryngeal edema and fibrosis follow-
ing radiotherapy for head and neck cancer can lead to
long-term problems with phonation and swallowing and
significantly compromise quality of life in cancer survivors
[1,2]. The incidence of swallowing dysfunction significantly
increases with intensified regimens, such as the addition of
chemotherapy to radiotherapy [3-5]. Several studies have
shown that reduced radiation dose to the larynx can dimin-
ish the effects of laryngeal dysfunction [6-9]. It remains
unclear which substructures of the larynx, when irradiated,
are most associated with swallowing dysfunction.
With the advent of technologies such as intensity–
modulated radiotherapy (IMRT), it is possible to selectively* Correspondence: bmittal@nmh.org
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risk (OARs), thereby reducing the risk of speech and swal-
lowing dysfunction [1]. This has prompted the Radiation
Therapy Oncology Group (RTOG) to require larynx
contours with dose constraints of mean dose ranging
from 36 to 45 Gy on many recent protocols. Larynx-
sparing radiotherapy requires that radiation oncologists
follow a common methodology for contouring the larynx
and its substructures. However, to date there has been no
validated standardized approach for contouring the larynx
and its substructures on axial computed tomography (CT)
scans or magnetic resonance imaging (MRI) scans used
for radiotherapy treatment planning (Table 1). The pur-
pose of this study was to devise standardized step-by-step
guidelines for contouring the larynx and its substructures
for use in IMRT plans and radiation induced speech and
swallowing dysfunction research.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Current RTOG head and neck protocols requiring larynx contours
Protocol Constraint Contouring instructions
RTOG 1016: Phase III trial of radiotherapy plus
cetuximab vs chemoradiotherapy in HPV-positive
oropharynx cancer
Reduce the dose as much as possible GSL: "triangular prism-shaped" volume that
begins just inferior to the hyoid bone and
extends to the cricoid cartilage inferiorly and
extends from the anterior commissure to
include the arytenoids. This includes the
infrahyoid but not the suprahyoid epiglottis
Glottic larynx mean dose≤ 20 Gy (2Gy/fx)
RTOG 1008: Phase II study of adjuvant concurrent
radiation and chemotherapy vs radiation alone in
resected high-risk malignant salivary gland tumors
Reduce the dose as much as possible
Larynx mean dose <35 Gy whenever
feasible (2 Gy/fx)
Same as RTOG 1016
RTOG 0920: Phase III study of postoperative radiation
therapy +/− cetuximab for locally advanced resected
head and neck cancer
Reduce the dose as much as possible
Larynx mean dose <45 Gy whenever
feasible (2 Gy/fx)
Same as RTOG 1016
RTOG 0912: Phase II study of concurrent
intensity-modulated radiation therapy,
paclitaxel, and pazopanib/placebo, for the
treatment of anaplastic thyroid cancer
Glottic larynx mean dose <60 Gy (2Gy/fx) None provided
Abbreviations: RTOG = Radiation Therapy Oncology Group; fx = fractions; GSL = glottic/supraglottic larynx.
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This study was part of an Institutional Review Board
(IRB)-approved project. Anatomic textbooks and radiologic
data were reviewed for descriptions of the larynx and its
substructures [10,11]. A board-certified neuroradiologist
assisted with identification of the larynx and laryngeal
substructures as well as adjacent structures including
the oral cavity, oropharynx, pharyngeal constrictors, and
hypopharynx using axial CT. The following step-by-step
technique for contouring the larynx and its substructures
on axial CT was devised. Similar guidelines can be used to
contour the larynx on T1-weighted MRI scans.
The study was approved by Northwestern University
institutional review board.
Use a bone window for the following:
1. Identify and contour the thyroid cartilage. The two
ala of the thyroid cartilage fuse anteriorly to form a
V-shaped shield. The superior and inferior cornua
project from the posterior free edges of the thyroid
cartilage.
2. Identify and contour the cricoid cartilage. The
cricoid cartilage forms a complete ring to form
the base and back of the larynx; it forms a narrow
rim anteriorly and a broad lamina posteriorly.
Superiorly, it begins just below the arytenoid
cartilages. Inferiorly, it ends just above the first
tracheal ring.
3. Identify and contour the arytenoid cartilages. This
pair of pyramid-shaped cartilages sits directly on the
posterior rim of the cricoid cartilage and posteromedial
to the thyroid cartilage.
4. Identify and contour the glottic larynx, which sits
on the same axial plane as the inferior edge of the
arytenoid cartilages. Anteriorly and laterally, the
glottic larynx is bound by the postero-medial edgeof the thyroid cartilage. Posteriorly, it is bound by
the anterior edge of the arytenoid cartilages.
5. Identify and contour the subglottic larynx. This area
is composed of the airspace and mucosa housed by
the cricoid cartilage. Superiorly, it begins at the slice
below the glottic larynx. Inferiorly, it ends at the
same level as the most inferior slice of the cricoid
cartilage.
Use a soft tissue window with good definition between
muscle and fat densities for the following:
6. Identify and contour the suprahyoid portion of the
epiglottis, a leaf-like cartilage that hovers over the
glottic inlet at and above the level of the hyoid bone.
Superiorly, it sits in air within the inferior oropharynx
and extends inferiorly to the level of the bottom
slice of the hyoid bone. Note that the epiglottis
forms the anterior wall of the laryngeal vestibule.
Typically, a clear fat plane can be seen wrapping
antero-laterally around the epiglottis and should
not be included.
7. Identify and contour the infrahyoid epiglottis. This
structure begins below the inferior aspect of the
suprahyoid epiglottis. Inferiorly, the epiglottis forms
a narrow stem that attaches to the posterior surface
of the angle of the thyroid cartilage and ends just
above the glottic larynx.
8. Because they are difficult to differentiate from one
another without direct visualization, identify and
contour the aryepiglottic folds and false vocal folds
as a single structure. Superiorly, the structure begins
at the superior aspect of the valleculae, forming the
lateral walls of this structure. Inferiorly, the
structure forms the lateral wall of the supraglottic
larynx and medial wall of the pyriform sinuses.
Figure 1 Atlas of the larynx and its substructures on
consecutive axial computed tomography (CT) slices: the thyroid
cartilage is depicted in green, the cricoid cartilage in orange,
the arytenoid cartilages in purple, the suprahyoid epiglottis in
red, the infrahyoid epiglottis in cyan, the aryepiglottic fold/
false vocal folds in blue, the supraglottic larynx in yellow, the
glottic larynx in lavender, and the subglottic larynx in
magenta. (A) Individual substructures of the larynx. (B) Major
divisions of the larynx.
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of the suprahyoid epiglottis and infrahyoid epiglottis
contours.
10. Create the supraglottic larynx OAR by combining
the contours for the epiglottis, arytenoids, and the
antero-medial wall of the aryepiglottic folds and false
vocal folds. The postero-lateral wall of the aryepiglottic
folds forms the medial wall of the pyriform sinuses and
is part of the hypopharynx.
11. Create the larynx OAR by combining the supraglottic
larynx, glottic larynx, subglottic larynx, thyroid
cartilage, and cricoid cartilage contours.
Using these guidelines, the larynx OARs were contoured
on the radiotherapy treatment-planning CT scans using
the Pinnacle treatment-planning system (ADAC Philips
Pinnacle 3 version 8.6™) for five consecutive patients who
were undergoing definitive chemoradiation for locally
advanced head-and-neck cancer of a non-larynx primary.
The OARs were delineated by one radiation oncologist
and reviewed and adjusted when considered appropriate
by one other radiation oncologist and a neuroradiologist.
These assessments resulted in a consensus determination
of the OARs. Examples of the OARs are shown in
Figures 1 and 2.
MRI provides visualization of soft-tissue planes superior
to that seen on CT and is frequently used in head and
neck cancers for tumor staging and determining surgical
resectability [11]. As such, to validate the accuracy of the
CT-based contouring guidelines, the larynx volumes were
drawn independently by one radiation oncologist on axial
MRI (T1-weighted, pre-contrast sequence) for the same
five patients using the CT-based contouring guidelines.
These contours were reviewed and verified by a board-
certified neuroradiologist resulting in a consensus contour.
Examples of the OARs are shown in Figure 3. The vol-
umes of the larynx and its substructures were compared
for both CT and MRI. For comparison between CT and
MRI contours, a two-sided paired t-test was performed
for each structure, and p values <0.05 were considered
significant.
Once internally agreed upon, the guidelines were used
to delineate the larynx on radiotherapy treatment plan-
ning CT scans for an additional 44 patients treated with
Figure 2 Digitally reconstructed radiographs of the major divisions of the larynx generated from contours shown in Figure 1B. This view
provides visual approximation of the supraglottic larynx, glottic larynx, and subglottic larynx volumes generated from our guidelines. The supraglottic
larynx is depicted in yellow, the glottic larynx in lavender, and the subglottic larynx in magenta. (A) Reconstructed sagittal view. (B) Reconstructed
coronal view.
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larynx primary. The contours were delineated by one
radiation oncologist and reviewed by another radiation
oncologist, resulting in consensus contours. Volumetric
comparisons were made between the guideline-based CT
contours for these 44 patients and the CT- and MRI-based
contours for the initial five patients using a two-sided
independent sample t-test for each structure, and p
values <0.05 were considered significant.Results
A total of 49 patients with head and neck squamous cell
carcinoma were included in this study. Forty patients
(82%) were men and 9 patients (18%) were women. The
primary tumor sites were oropharynx, unknown primary,
nasopharynx, and hypopharynx for 37 (76%), 9 (18%), 2
(4%), and 1 (2%) patients, respectively. No patients had pri-
mary laryngeal cancer. Forty-four patients had stage IV
disease, 4 had stage III disease, and 1 had stage II disease.
Median age at diagnosis was 54 years (range, 30–74).
The larynx and its substructures were successfully cre-
ated independently on CT and MRI datasets initially for
five patients using the proposed larynx OAR guidelines.
Table 2 shows the volumes of the OARs contoured on
both MRI and CT. Differences in OAR volume (cubic
centimeter) were not statistically different.
For the 44 additional patients contoured, the mean CT-
based larynx volume was 37.2 ± 9.2 cm3. Mean volumes for
the supraglottic larynx, glottic larynx, and subglottic larynx
were 13.9 ± 3.7 cm3, 3.0 ± 0.7 cm3, and 5.6 ± 1.9 cm3, re-
spectively. Comparison of these 45 CT-based contours
with the five initial CT-based contours and MRI-based
contours showed no significant difference in OAR volumes.Table 3 summarized the volumes for the complete set of
OARs in the additional patients.
Since there is evidence in the literature that the larynx
is larger in men than in women, we also decided to look
at larynx volume by gender. Mean volumes for the
CT-based larynx contours were significantly smaller
for women than for men (p < 0.05). For women, mean
volumes for the larynx, supraglottic larynx, glottic larynx,
and subglottic larynx were 20.1 ± 3.0 cm3, 7.4 ± 1.6 cm3,
2.2 ± 0.5 cm3, and 2.9 ± 0.6 cm3, respectively. For men,
mean volumes for the larynx, supraglottic larynx, glottic
larynx, and subglottic larynx were 40.7 ± 4.9 cm3, 15.1 ±
2.3 cm3, 3.2 ± 0.6 cm3, and 6.1 ± 1.6 cm3, respectively.
Discussion
In our study, we developed simple step-by-step CT-based
guidelines for delineating the larynx and its substructures
within radiation treatment plans for patients undergoing
IMRT for head and neck cancer. This study provides
initial validation that these contouring guidelines can
be applied to radiotherapy planning for CT scans by com-
paring them to MRI contours. These guidelines can po-
tentially serve as a research tool and can help reduce
observer variability on OAR delineation, allowing for im-
proved comparison and interpretation of dose–volume
effects for these OARs from different studies.
Radiation–associated dysphagia is a common and often
permanent late complication of radiotherapy to the head
and neck. Only a limited number of studies have attempted
to define the most important anatomic structures whose
dose–volume parameters may have a major effect on swal-
lowing. Candidate structures that have been associated
with functional dysphagia endpoints have included the
larynx, pharyngeal constrictors, and upper esophagus
Figure 3 Atlas of the larynx and its substructures on consecutive
axial magnetic resonance imaging (MRI) slices, T1-weighted,
pre-contrast sequence: the thyroid cartilage is depicted in green,
the cricoid cartilage in orange, the arytenoid cartilages in purple,
the suprahyoid epiglottis in red, the infrahyoid epiglottis in cyan,
the aryepiglottic fold/false vocal folds in blue, the supraglottic
larynx in yellow, the glottic larynx in lavender, and the subglottic
larynx in magenta. (A) Individual substructures of the larynx. (B) Major
divisions of the larynx.
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constrictors and esophagus exist and are commonly
used in daily practice and clinical trials [7,12,14-16].
Other sets of proposed guidelines for the larynx have
been put forward but are sparse; none provide clear,
comprehensive guidelines for delineating the larynx in
its entirety [7,12,14-16]. To our knowledge, delineation
guidelines for contouring laryngeal substructures, as pre-
sented in this paper, do not exist.
It should be noted that imaging modalities other than
CT, such as MRI, might improve visualization of the lar-
ynx and surrounding structures. MRI, with its superior
soft-tissue contrast, can help to discriminate the laryn-
geal substructures from surrounding muscle and fat and
can provide the best tumor visibility [10,11]. Therefore,
the CT-based contouring guidelines developed here were
also used to contour on axial MRI for five patients. The
T1-weighted, pre-contrast sequence was selected because
it generally has good anatomic detail, with fat as inherent
contrast, and is less susceptible to artifact as compared
to other sequences. Volumetric comparison showed the
CT and MRI volumes to be comparable, suggesting that
CT-based delineation is adequate for evaluation of theseTable 2 CT/MRI comparison of OAR volumes for five
patients with locally advanced head and neck cancer
Organ at risk CT (mean ± SD) MRI (mean ± SD) p value
Thyroid cartilage, cm3 8.51 ± 3.42 8.32 ± 3.07 0.50
Cricoid cartilage, cm3 3.89 ± 1.48 3.84 ± 1.49 0.82
Arytenoid cartilages, cm3 1.12 ± 0.28 1.12 ± 0.28 0.81
Suprahyoid epiglottis, cm3 1.77 ± 0.93 1.86 ± 0.72 0.58
Infrahyoid epiglottis, cm3 0.96 ± 0.80 0.84 ± 0.62 0.42
Epiglottis, cm3 2.73 ± 0.95 2.63 ± 0.87 0.17
Aryepiglottic folds/false
vocal folds, cm3
7.03 ± 3.39 7.08 ± 3.47 0.58
Supraglottic larynx, cm3 12.83 ± 3.78 12.19 ± 4.71 0.23
Glottic larynx, cm3 3.14 ± 0.37 3.25 ± 0.49 0.33
Subglottic larynx, cm3 4.96 ± 1.52 5.15 ± 1.43 0.16
Larynx, cm3 34.39 ± 9.85 35.01 ± 9.47 0.09
Abbreviations: OAR = organ at risk; SD = standard deviation; CT = computed
tomography-based volumes; MRI = magnetic resonance imaging-based
volumes.
Table 3 CT-based larynx OAR volumes for 44 additional
patients with locally advanced head and neck cancer
p value




Thyroid cartilage, cm3 10.2 ± 3.11 0.26 0.21
Cricoid cartilage, cm3 3.83 ± 1.29 0.93 0.99
Arytenoid cartilages, cm3 1.00 ± 0.39 0.55 0.52
Suprahyoid epiglottis, cm3 1.94 ± 0.86 0.67 0.83
Infrahyoid epiglottis, cm3 0.96 ± 0.51 0.99 0.61
Epiglottis, cm3 2.91 ± 1.09 0.73 0.59
Aryepiglottic folds/false
vocal folds, cm3
6.11 ± 1.72 0.32 0.29
Supraglottic larynx, cm3 13.87 ± 3.68 0.56 0.36
Glottic larynx, cm3 2.99 ± 0.70 0.64 0.44
Subglottic larynx, cm3 5.55 ± 1.94 0.52 0.66
Larynx, cm3 37.20 ± 9.20 0.53 0.62
Abbreviations: OAR = organ at risk; SD = standard deviation; CT = computed
tomography-based volumes; MRI = magnetic resonance imaging-based
volumes; pts = patients.
*Comparisons are between volumes obtained from 44 additional patients and
five initial patients.
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for contouring on MRI. This may be of interest as new
radiotherapy treatment systems with online MR imaging
are developed and gain wider use in the clinic [17].
To decrease radiation to organs at risk, it is essential
to accurately contour the structures of interest. A number
of investigators have reported on larynx–sparing IMRT
techniques, such as junctioned IMRT and IMRT with
modulated arcs, acknowledging that if the larynx is in-
corporated into the optimization process, larynx dose can
be reduced significantly from a mean dose of approximately
50 Gy, typically found when laryngeal sparing is not
attempted, to 25 to 40 Gy, while maintaining acceptable
target coverage [18-22]. Delineation of the larynx and
its substructures has not been specified in the majority of
these studies.
However, some investigators express concern that re-
ducing dose to the larynx in this way could compromise
dose distribution elsewhere [23]. To address this issue in
a meaningful way, accurate contouring and planning of
the laryngeal OARs are critical [24]. Standardization
of delineation protocols should help to improve such
optimization of larynx-sparing radiation therapy in head
and neck cancer.
When using these guidelines, it should be noted that
differences exist among patients, and the delineation of
individual variants should be addressed by the treating
physicians. For example, our findings corroborate, using
CT scan, the finding by Hollien, et al. who estimated that
the size of the larynx is larger in men than in women using
x-ray technology [25]. Furthermore, when the tumor altersthe normal anatomy, delineation of the involved laryngeal
substructures may be of limited clinical utility as they may
have impaired functionality as a result of tumor invasion.
Finally, imaging of the larynx can be challenging given
its mobility and its proximity to other structures (e.g.,
pharyngeal constrictors) that can cause motion artifact.
As such, imaging acquisition should be optimized to
minimize artifact from breathing and swallowing: the neck
should be hyperextended to help reduce the frequency of
swallowing, and the patient should be instructed to resist
swallowing or coughing [11].
The contouring guidelines presented provide an easy
tool for comprehensively delineating larynx and its sub-
structures. Our study has limitations, as we did not as-
sess inter-delineator variability or take laryngeal motion
into account. However, these guidelines are a consensus
opinion of an experienced head and neck radiation on-
cologist and a neuro-radiologist, based upon the literature
review of laryngeal anatomy. It remains to be seen if any
single or multiple laryngeal substructures play a preferen-
tial and significant role in speech and swallowing. Further
validation within the context of a prospective clinical trial
is required in order to assess if utilizing this contouring
approach would result in lower incidence of treatment-
induced adverse events; mainly hoarseness of voice, as-
piration and dysphagia. Towards this end, our study can
serve as a research tool in contouring and investigating
dose-volume constraints of laryngeal substructures. The
guidelines will promote consistency in contouring and
reducing inter-observer variation, which has been shown
to have a large impact on target and normal tissue delinea-
tion [26].
Conclusions
We provide a precise and accurate method for delineating
the larynx and its substructures on treatment-planning
CT scans. These guidelines should be validated and can be
used as a research tool to understand clinical signifi-
cance of contouring laryngeal substructures and their
importance in dose-optimization. The validated contouring
guidelines will reduce inter-observer variability and lead to
an improved understanding of dose-volume relationship
of larynx and its substructures to consequent speech and
swallowing dysfunction.
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